Patents by Inventor Andrew Land

Andrew Land has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dose synthesis card for use with automated biomarker production system
    Patent number: 10109385
    Abstract: Microfluidic radiopharmaceutical production system and process for synthesizing per run approximately, but not less than, ten (10) unit doses of radiopharmaceutical biomarker for use in positron emission tomography (PET). A radioisotope from an accelerator or other radioisotope generator is introduced into a reaction vessel, along with organic and aqueous reagents, and the mixture heated to synthesize a solution of a pre-selected radiopharmaceutical. The solution is purified by passing through a combination of solid phase extraction purification components, trap and release components, and a filter. The synthesis process reduces waste and allows for production of biomarker radiopharmaceuticals on site and close to the location where the unit dose will be administered to the patient.
    Type: Grant
    Filed: February 10, 2015
    Date of Patent: October 23, 2018
    Assignee: ABT Molecular Imaging, Inc.
    Inventors: Aaron McFarland, Atilio Anzellotti, Daniel Hillesheim, Clive Brown-Proctor, Mark Haig Khachaturian, Andrew Land
  • Dose Synthesis Card for Use with Automated Biomarker Production System
    Publication number: 20150157743
    Abstract: Microfluidic radiopharmaceutical production system and process for synthesizing per run approximately, but not less than, ten (10) unit doses of radiopharmaceutical biomarker for use in positron emission tomography (PET). A radioisotope from an accelerator or other radioisotope generator is introduced into a reaction vessel, along with organic and aqueous reagents, and the mixture heated to synthesize a solution of a pre-selected radiopharmaceutical. The solution is purified by passing through a combination of solid phase extraction purification components, trap and release components, and a filter. The synthesis process reduces waste and allows for production of biomarker radiopharmaceuticals on site and close to the location where the unit dose will be administered to the patient.
    Type: Application
    Filed: February 10, 2015
    Publication date: June 11, 2015
    Inventors: Aaron McFarland, Atilio Anzellotti, Daniel Hillesheim, Clive Brown-Proctor, Mark Haig Khachaturian, Andrew Land